Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Summary FOXO4-DRI is a pioneering senolytic peptide designed to selectively target and eliminate senescent cellsthose that have lost their ability to divide yet persist in a pro-inflammatory, dysfunctional state
A specialist can help determine if this treatment is right for you and guide you on the safest and most effective method
PMC 8442736
However, their effect may be particularly dose-dependent and more research is needed before specific recommendations can be made
doi: 10.1038/s12276-023-00960-y 151 La FataGWeberPMohajeriMH
Journal of Clinical Monitoring and Computing
US$ 28.92
US$ 27.41
US$ 26.58
US$ 25.46
